Neoclerodane diterpenes as a novel scaffold for μ opioid receptor ligands

被引:122
作者
Harding, WW
Tidgewell, K
Byrd, N
Cobb, H
Dersch, CM
Butelman, ER
Rothman, RB
Prisinzano, TE [1 ]
机构
[1] Univ Iowa, Coll Pharm, Div Med & Nat Prod Chem, Iowa City, IA 52242 USA
[2] NIDA, Clin Psychopharmacol Sect, IRP, NIH,DHHS, Baltimore, MD 21224 USA
[3] Rockefeller Univ, Lab Biol Adict Dis, New York, NY 10021 USA
关键词
D O I
10.1021/jm048963m
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Structural modification of salvinorin A, the active component of Salvia divinorum, has resulted in the synthesis of novel neoclerodane diterpenes with opioid receptor affinity and activity. We report in this study a nonnitrogenous neoclerodane diterpene with mu opioid receptor affinity (13) that is an agonist at mu opioid receptors. This represents the identification of a novel structural class of mu opioid receptor agonists.
引用
收藏
页码:4765 / 4771
页数:7
相关论文
共 46 条
[1]   Etorphines: mu-opioid receptor-selective antinociception and low physical dependence capacity [J].
Aceto, MD ;
Harris, LS ;
Bowman, ER .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 338 (03) :215-223
[2]  
[Anonymous], COMPREHENSIVE MED CH
[3]   Cellular localization and distribution of the cloned mu and kappa opioid receptors in rat gastrointestinal tract [J].
Bagnol, D ;
Mansour, A ;
Akil, H ;
Watson, SJ .
NEUROSCIENCE, 1997, 81 (02) :579-591
[4]   The invention of radical reactions .37. A convenient radical synthesis of dialkyl diselenides from carboxylic acids. [J].
Barton, DHR ;
Fontana, G .
TETRAHEDRON, 1996, 52 (34) :11163-11176
[5]   The plant-derived hallucinogen, salvinorin A, produces κ-opioid agonist-like discriminative effects in rhesus monkeys [J].
Butelman, ER ;
Harris, TJ ;
Kreek, MJ .
PSYCHOPHARMACOLOGY, 2004, 172 (02) :220-224
[6]   SNC 80 and related δ opioid agonists [J].
Calderon, SN ;
Coop, A .
CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (07) :733-742
[7]   Salvinorin A, an active component of the hallucinogenic sage Salvia divinorum is a highly efficacious κ-opioid receptor agonist:: Structural and functional considerations [J].
Chavkin, C ;
Sud, S ;
Jin, WZ ;
Stewart, J ;
Zjawiony, JK ;
Siebert, DJ ;
Toth, BA ;
Hufeisen, SJ ;
Roth, BL .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 308 (03) :1197-1203
[8]  
COOP A, 2004, NIDA RES MONOGR, V184, P135
[9]   PROBES FOR NARCOTIC RECEPTOR MEDIATED PHENOMENA .18. EPIMERIC 6-ALPHA-IODO-3,14-DIHYDROXY-17-(CYCLOPROPYLMETHYL)-4,5-ALPHA-EPOXYMORPHINANS AND 6-BETA-IODO-3,14-DIHYDROXY-17-(CYCLOPROPYLMETHYL)-4,5-ALPHA-EPOXYMORPHINANS AS POTENTIAL LIGANDS FOR OPIOID RECEPTOR SINGLE PHOTON-EMISSION COMPUTED-TOMOGRAPHY - SYNTHESIS, EVALUATION, AND RADIOCHEMISTRY OF [I-125] 6-BETA-IODO-3,14-DIHYDROXY-17-(CYCLOPROPYLMETHYL)-4,5-ALPHA-EPOXYMORPHINAN [J].
DECOSTA, BR ;
IADAROLA, MJ ;
ROTHMAN, RB ;
BERMAN, KF ;
GEORGE, C ;
NEWMAN, AH ;
MAHBOUBI, A ;
JACOBSON, AE ;
RICE, KC .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (15) :2826-2835
[10]  
EDDY NB, 1953, J PHARMACOL EXP THER, V107, P385